Pediatr. praxi. 2015;16(3):179-182

Bartter syndrome - clinical genetic analysis

prof.MUDr.Zdeněk Doležel, CSc.1, prof.Hae II Cheong, M.D.2,3, MUDr.Adéla Holeszová4, MUDr.Zdeňka Ráčilová5, MUDr.Denisa Pavlovská5, MUDr.Dana Dostálková1, MUDr.Jiří Štarha, Ph.D.1
1 Pediatrická klinika LF MU a FN Brno
2 Department of Pediatrics, Seoul National University Childrens ´s Hospital, Seoul, Korea
3 Research Coordination Center for Rare Diseases, Seoul National University Hospital, Seoul, Korea
4 Dětské oddělení, Nemocnice s poliklinikou Havířov, p. o.
5 Klinika dětské radiologie LF MU a FN Brno

Bartter syndrome is a group of inherited, salt-losing tubulopathies presenting as hypokalemic metabolic alkalosis with normotensive

hyperreninemia and hyperaldosteronism. Two segments along the distal nephron are primarily involved in the pathogenesis of the syndrome:

the thick ascending limb of Henle´s loop, and the distal convoluted tubule. Frequently, pediatricians are the first professionals to

attend to these patients and it is therefore important to be aware of this condition, since prognosis is better with earlier diagnosis and



treatment: The authors describe the results of a genetic analysis and follow-up of patients with Bartter syndrome.

Keywords: Bartter syndrome, genetic analysis, hypokalemia, growth failure

Published: June 30, 2015  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Doležel Z, II Cheong H, Holeszová A, Ráčilová Z, Pavlovská D, Dostálková D, Štarha J. Bartter syndrome - clinical genetic analysis. Pediatr. praxi. 2015;16(3):179-182.
Download citation

References

  1. Reis GS, Miranda DM, Barros Pereira PC, et al. Application of molecular biology at the approach of Bartter's syndrome. Case report. J Bras Nefrol 2012; 34: 82-86. Go to original source... Go to PubMed...
  2. Stechman M, Loh NY, Thakker RV. Genetic causes of hypercalciuric nephrolithiasis. Pediatr Nephrol 2009; 24: 2321 - 2332. Go to original source... Go to PubMed...
  3. Seyberth HW, Schlingmann KP. Bartter- and Gitelman-like syndromes: salt-losing tubulopathies with loop or DCT defects. Pediatr Nephrol 2011; 26: 1789-1802. Go to original source... Go to PubMed...
  4. Kmoníčková M, Bláhová K, Kutílek Š, et al. Neonatální Bartterův syndrom. Pediatr. praxi 2013; 14: 123-125.
  5. Özkan B, Çayir A, Koşan C, et al. Cystinosis presenting with findings of Bartter syndrome. J Clin Res Ped Endo 2011; 32: 101-104. Go to original source...
  6. Egritaş O, Dalgiç B, Wedenoja S. Congenital chloride diarrhea misdiagnosed as Bartter syndrome. Turk J Gastroenterol 2011; 22: 321-323. Go to original source...
  7. Tajima T, Nawate M, Takahashi Y, et al. Molecular analysis of the CLCNKB gene in Japanese patients with classic Bartter syndrome. Endocrine Journal 2006; 53: 647-652. Go to original source... Go to PubMed...
  8. Sharma PK, Saikia B, Sharma R, et al. Genetic analysis in Bartter syndrome from India. Indian J Pediatr 2014; 81: 1095-1098. Go to original source... Go to PubMed...
  9. Ishimori S, Kaito H, Matsunoshita N, et al. SLC26A3 gene analysis in patients with Bartter and Gitelman syndromes and the clinical characteristics of patients with unidentified mutations. Kobe J Med Sci 2013; 59: E36-E43. Go to PubMed...
  10. Kleta R, Basoglu C, Kuwertz-Bröking E. New treatment options for Bartter's syndrome. N Engl J Med 2011; 343: 661. Go to original source... Go to PubMed...
  11. Klovrzová S, Horák P, et al. Individuálně připravovaná léčiva pro pediatrii. Galén 2013: 103s.
  12. Nascimento CLP, Garcia CL, Schvatsman BGS, et al. Treatment of Bartter syndrome. Unsolved issue. J Pediatr (Rio J) 2014; 90: 512-517. Go to original source... Go to PubMed...
  13. Buyukcelik M, Keskin M, Kilic BD, et al. Bartter syndrome and growth hormone deficiency: three cases. Pediatr Nephrol 2012; 27: 2145-2148. Go to original source... Go to PubMed...




Pediatrics for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.